193
Participants
Start Date
December 11, 2017
Primary Completion Date
May 26, 2022
Study Completion Date
May 26, 2022
Phentermine-Topiramate
Extended Release at dose of 7.5/46 mg oral daily
Liraglutide
dose of 3 mg subcutaneous daily
Naltrexone/bupropion
Oral naltrexone extended-release/bupropion extended-release at dose of 32/360 mg oral daily (divided in 2 tables in morning and 2 tablets in evening)
Phentermine
15-37.5 mg oral daily
Mayo Clinic in Rochester, Rochester
Lead Sponsor
Mayo Clinic
OTHER